Background: The aim of this study is to evaluate clinical outcomes of a concept for non-surgical peri-implantitis combining stepwise mechanical debridement measures with adjuvant povidone-iodine application with and without systemic antibiotics.
comprises Gram-negative anaerobes and opportunistic pathogens, and shows differences from periodontitis microflora. 4 According to a cause-related approach, removal of the peri-implant biofilm is the most important step for prevention and therapy of peri-implant diseases.
Although surgical therapies with open-flap debridement procedures, resective, or regenerative approaches have been shown to be effective, 5, 6 conventional non-surgical treatment of peri-implant infections have been documented to provide limited success rates. [7] [8] [9] In a recent meta-analysis the weighted mean bleeding on probing (BOP) and probing depth (PD) reductions after conventional non-surgical periimplantitis therapy were 31.12% and 0.71 mm, respectively. 10 In accordance with the strategy of periodontal treatment of teeth, it would be desirable to find ways to increase effectiveness of the anti-infectious non-surgical therapy to limit surgical treatments to those cases with severe peri-implantitis. To this end, it is necessary to improve efficacy of implant decontamination, which is, compared with teeth, complicated by the design of macro-and microthreads of the implants. To compensate for this problem and improve biofilm elimination, alternative decontamination methods, such as use of glycine powder air polishing (GPAP), 11, 12 erbium:yttriumaluminum-garnet (Er:YAG) laser, 13, 14 and antimicrobial photodynamic therapy (aPDT), 15, 16 as well as additional antimicrobial strategies such as application of chlorhexidine (CHX) chips, 17 local antibiotics, 15, 18, 19 or chloramine 20 have been suggested. According to a meta-analysis of Faggion et al. 9 the additional PD reduction by the adjuvant use of antimicrobial measures for non-surgical peri-implantitis therapy compared with debridement alone was 0.22 mm for CHX gel, 0.23 mm for Er:YAG laser, 0.33 mm for GPAP, 0.34 mm for aPDT, 0.40 mm for CHX chips, and 0.49 mm for local antibiotics. The follow-up time of the studies included in the aforementioned comparisons varied between 4 and 12 months.
Considering the restricted accessibility of peri-implant pockets and the pronounced inflammatory cell infiltrate compared with periodontitis, results of the non-surgical treatment of peri-implantitis might be improved by: 21 1) removal of the peri-implant biofilm by a combination of different methods of mechanical debridement; 2) reduction of inflammatory infiltrate by soft tissue curettage (STC); and 3) an adjuvant antiseptic therapy. Thereby, povidone-iodine might be a promising alternative to previously reported antiseptics with several advantages: 22, 23 povidone-iodine has a broad antibacterial spectrum, including Gram-positive and Gram-negative bacteria and Staphylococci spp., but also Candida albicans and several anaerobic periodontal bacteria (in particular Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and Fusobacterium nucleatum). 23, 24 Further, it has low cost and a very limited risk for developing bacterial resistance. 25 For non-surgical therapy of periodontitis, clinical and microbial benefits for the adjuvant application of povidone-iodine have already been documented, [22] [23] [24] whereas the antimicrobial potential for peri-implantitis has not been evaluated yet.
Based on the aforementioned aspects, the aim of the present prospective cohort study is to evaluate clinical results of a concept for non-surgical treatment of peri-implantitis combining: 1) submucosal debridement with an ultrasonic device; 2) submucosal STC; 3) submucosal GPAP; and 4) a subsequent adjunctive disinfection of peri-implant pockets with a 10% povidone-iodine solution. Furthermore, the benefit of an adjuvant systemic antibiotic therapy (amoxicillin and metronidazole [AM]) is analyzed.
MATERIALS AND METHODS
A total of 61 patients (29 males and 32 females, aged 45 to 83 years; mean age: 62 years) with generalized chronic periodontitis (CP) were recruited, from November 2013 to April 2015, in a private dental practice in Aachen, Germany, for treatment of periodontitis and peri-implantitis, and were followed up for 12 months. The study was performed in accordance with the Helsinki Declaration of 1975, as revised in 2013, and the study protocol was approved by the ethics committee of the University of Aachen, Aachen, Germany (EK 046/16). All patients gave their signed consent for their voluntary participation in the study.
Patients were considered for the study in the case of presence of the following inclusion criteria: 1) generalized moderate or severe CP according to the criteria of Armitage 26 with at least 30% of sites with clinical attachment level (CAL) of 3 to 4 mm (moderate periodontitis) or ≥5 mm (severe periodontitis), respectively; and 2) at least one screw-type titanium implant with peri-implantitis based on the following criteria: radiographic crestal bone loss of > 2 mm; PD of ≥5 mm at ≥1 peri-implant site with concomitant BOP and/or suppuration. Patients were not included if they had systemic diseases (e.g., diabetes mellitus, osteoporosis) or conditions that might affect peri-implant inflammation. Furthermore, intake of medication known to cause or increase gingival overgrowth or to affect bone metabolism (antiresorptive drugs), systemic antibiotic therapy at least 3 months prior to the study entry, and pregnancy also led to exclusion from the study. Of the 48 patients who were assessed as eligible for the study, 45 individuals with 164 implants with peri-implantitis completed the 12-month follow-up. Of those, 24 patients received non-surgical therapy of teeth and implants with adjuvant systemic AM, whereas in 21 patients, non-surgical therapy was carried out without antibiotics. The study flow chart is shown in Figure 1 . Among all patients, there were five smokers, three in the group with and two in the group without AM. Demographic data are listed in Table 1 . Number of implants with peri-implantitis 164 90 74
Examination of clinical parameters
All periodontal/peri-implant examinations were carried out by one examiner (JMS) at baseline and 1 year after nonsurgical therapy. Clinical parameters included plaque index (PI), 27 gingival index (GI), 27 PD, CAL, and BOP. All teeth and implants were examined at six sites per tooth/implant (disto-buccal, buccal, mesio-buccal, disto-oral, oral, mesiooral) using a 0.2 N pressure-calibrated probe. * In cases in which periodontal probing was difficult because of discomfort or pain (n = 6), probing was performed under local anesthesia. In all other patients, probing was possible without anesthesia. * Aesculap Parodontometer DB764R UNC 15, Aesculap, Tuttlingen, Germany.
In analogy to the cemento-enamel junction of teeth, the shoulder of the implants was considered as a landmark for assessment of mucosal recessions and CAL. Further, the percentage of peri-implant/periodontal pockets with PD > 4 mm and positive BOP were measured. To ensure acceptable intraexaminer reliability, the examiner was calibrated to show an agreement of > 90% within 1 mm by duplicate measurements of PD and CAL of randomly selected teeth (n = 10) and implants (n = 10).
Non-surgical treatment of implants and teeth
In all patients, professional supragingival/supramucosal tooth and implant cleaning was performed at the first session.
F I G U R E 2
Combined mechanical and antiseptic non-surgical therapy of peri-implantitis, including initial ultrasonic debridement (A), followed by a STC using a sharp metal curet (B), a subsequently performed GPAP using a subgingival nozzle (C), and a repeated subgingival application of povidone-iodine for final antiseptic treatment (D)
Thereby, patients received oral hygiene instructions that considered their individual needs and included advice to use interdental floss * between and around the neck of all implants. At the second appointment, all peri-implantitis diseased implants were treated under local anesthesia according to the following concept: 1) submucosal depuration of the implant surfaces with a piezoelectric ultrasonic device † and a metal tip (Fig. 2A) ; 2) STC with removal of granulation tissue using a sharp universal metal curet ‡ (Fig. 2B ); 3) deep GPAP using an air polishing device § with a submucosal flexible plastic tip ¶ and glycine powder # (Fig. 2C) ; and 4) a subsequent submucosal application of 10% povidone-iodine solution ‖ (Fig. 2D) . Thereby, GPAP was performed with a reduced pressure of one bar by moving the handpiece into the peri-implant pockets with a circular coronoapical movement parallel to the implant axis and an instrumentation time of ≈ 20 seconds per implant. Submucosal povidone-iodine application was done using a syringe with a blunt needle that was moved up to the bottom of each pocket; povidone-iodine was slowly released for ≈ 10 seconds per implant, which was repeated three times every 3 minutes. One week later application of povidone-iodine was repeated. The same concept was applied for all periodontitisaffected teeth (PD ≥ 4 mm) with the exception of the STC. Instead of the curettage, a deep scaling and root planing of the teeth was done using Gracey curets. * * In cases with severe CP, amoxicillin (1,500 mg/day) and metronidazole (1,200 mg/day) were prescribed for 7 days. 28 Every 3 months supportive therapy, including hygiene instructions and supramucosal/supragingival plaque control, was performed ( Fig. 1 ).
Data analyses
Mean values and standard deviations (SDs) of all periodontal parameters (PI, GI, PD, CAL, BOP, and percentage of sites with PD > 4 mm and BOP) at baseline and 12 months after non-surgical therapy of peri-implantitis and periodontitis were analyzed separately for patients with and without intake of systemic antibiotics (AM). Intragroup analysis for changes between baseline and 12-month results were calculated using the paired Student t test and the Wilcoxon signedrank test. Intergroup comparisons between patients with and without AM were performed using the Mann-Whitney ranksum test. Level of significance was set at = 0.05. All statistical analyses were performed using a statistical software package. † † BOP, mean ± SD (%) Baseline 57. For all comparisons between baseline versus 12 months postoperative: P < 0.05.
T A B L E 2
Clinical parameters of implants at baseline and 12 months after non-surgical therapy
Power calculation
The sample size of 45 patients with at least one implant with peri-implantitis (24 without AM; 21 with AM) resulted in a power of 88% for the group without AM and 84% for those with AM to detect a 1-mm difference in CAL. The calculated standard deviations were based on outcomes by John et al. 12 
RESULTS
Plaque and gingiva indices did not show statistically significant differences at baseline. Both indices were significantly reduced after 12 months in patients with and without AM ( Table 2 ).
PD and CAL
Mean values with SDs of clinical parameters of all treated implants at baseline and the 12-month follow-up are listed in Table 2 . In groups with and without AM, baseline parameters of PD and CAL did not show statistically significant differences. Baseline PD values for all implants treated without (4.7 ± 1.1 mm) and with AM (5.0 ± 0.8 mm) were reduced by 1.4 ± 0.7 mm and 1.3 ± 0.8 mm, respectively. In accordance, baseline CAL measurements in the group without (5.3 ± 1.1 mm) and with AM (5.5 ± 0.9 mm) were changed by 1.3 ± 0.7 mm and 1.2 ± 0.9 mm. All PD and CAL changes between baseline and the 12-month follow-up were statistically significant (P < 0.05) and comparable with the changes of PD and CAL in periodontitis-affected teeth (Table 3) . However, there was no statistically significant difference in the changes of these parameters between groups with and without antibiotics, both for implants and for teeth. When only implants with initially deep pockets (PD > 6 mm) were analyzed, the change of PD and CAL values were 2.3 ± 1.3 mm and 2.0 ± 1.6 mm (without AM) compared with slightly increased values of 2.6 ± 2.0 mm and 2.6 ± 2.0 mm (with AM), respectively. Again, differences between both groups were not statistically significant. Similar results were found for teeth, with a non-significant trend toward an increased change of PD and CAL values in the AM group compared with the group without AM (Table 4) .
BOP
At all implants, more than half of all examined peri-implant sites presented BOP at baseline without a statistical difference between the group with and without AM ( Table 2) . Twelve months after non-surgical therapy, the percentage of sites with positive BOP were significantly reduced by 33.4% ± 17.2% in the group without AM and 32.3% ± 26.3% in the AM group (Table 3 ). The reduction was even more pronounced (44.0% ± 41.7% without AM, 52.2% ± 41.8% with AM), when only sites with initial PD > 6 mm were analyzed (Table 4) . Although there was a tendency toward a higher reduction of BOP sites in the AM group, all intergroup comparisons showed no statistical significance. A similar reduction of the percentage of BOP-positive sites were found at all teeth, however, with a (non-significantly) more pronounced difference between the AM group (61.7% ± 27.4%) and the group without AM (46.5% ± 39.6%) at initially deep pockets (Tables 3, 4 ).
Sites with peri-implant and periodontal treatment need
To consider the treatment need of peri-implant and periodontal pockets before and after therapy, the percentage of sites with persisting pockets with PD > 4 mm and concomitant BOP was evaluated separately. Although the baseline percentage of sites with PD > 4 mm with BOP in the AM group (39.7% ± 15.8%) was higher than in the non-AM group (27.5% ± 21.8%), the difference was not statistically significant ( Table 2) . Reduction of sites with treatment need at implants was significantly higher in the group with AM (31.8% ± 12.6%) than in the group without AM (20.8% ± 14.7%). Moreover, changes were more pronounced at implants than at teeth (Table 3) . When only deep pockets were considered, reduction of sites with treatment need at implants was even higher (44.0% ± 41.7% without AM; 53.5 ± 42.5 with AM); however, there was not a statistically significant difference between groups. Teeth with initially deep pockets showed similar tendencies, with a trend toward a higher reduction of treatment need (Table 4) .
T A B L E 3 Changes of clinical parameters in implants and teeth
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DISCUSSION
In the present study, the aim was to investigate clinical parameters of a novel concept of non-surgical therapy of periimplantitis combining different mechanical and antiseptic treatment aspects. To the best knowledge of the authors, this is the first study comparing outcomes of non-surgical therapy of implants with peri-implantitis and teeth with periodontitis with and without systemic antibiotics. For all peri-implant evaluations the implant has been chosen as the statistical unit.
This was done to avoid the risk of over-or underestimation of peri-implant disease parameters by the (random) selection of only one implant per patient. All 45 study participants who were included for analysis were compliant and had an acceptable oral hygiene (PI < 1). Further, during the study period, changes of PI and GI did not significantly differ between patients with and without antibiotic treatment. Thus, it can be supposed that oral hygiene has not biased the primary outcomes.
Periodontal probing, in particular around implants, can be very technique-sensitive and might be challenged by exposed submucosal threads and influenced by the inflammatory state of the pocket. To reduce this bias, periodontal probing was only performed by one experienced, trained, and calibrated examiner with the use of a pressure-calibrated probe with a probing force of 0.2 N. However, it should be considered that according to the results of Gerber et al. 29 a probing force > 1.5 N at implants might lead to an increase of iatrogenic (false) positive bleeding. This is why BOP outcomes must be interpreted with the necessary caution. Nevertheless, changes before and after treatment as well as between groups are unlikely to be biased by this issue since all measurements were equally calibrated.
Results show that the combination of a mechanical debridement using an ultrasonic device, STC, and GPAP with repeated application of povidone-iodine led to a significant reduction of mean PD, mean CAL, and percentage of sites with BOP. Mean PD reduction of all treated implants was 1.4 mm without systemic antibiotics, which was twice as high as after conventional non-surgical therapy using curets (0.71 mm) according to a recent meta-analysis. 10 Also in comparison to studies with similar initial PDs that examined the additional use of laser therapy, 30, 31 aPDT, 32 air polishing with aPDT, 15 local antibiotics, 15 or application of 1% CHX gel, 12, 19 the herein observed PD reduction was higher than in the aforementioned studies. When only deep peri-implant pockets with PD of ≥7 mm or more were analyzed, mean PD reduction increased by 1.0 to 2.4 mm. This was comparable to the results of Machtei et al., 17 who treated patients with very high mean initial peri-implant pockets (PD > 7 mm) using repeated application of CHX chips.
Similar tendencies were revealed for the change of the mean CAL, i.e., PD reduction was less likely caused by development of recessions but rather possibly by formation of a reattachment, of which the quality could not be proven in this study.
The anti-inflammatory effect of the presented treatment concept can be demonstrated by the significant reduction of the percentage of BOP by one-third of all and by half of the deep peri-implant pockets. Further, percentage of sites with PD > 4 mm with BOP, which was considered a parameter of sites with treatment need, was significantly reduced from 27.5% to 6.7%, whereas reduction of deep pockets was more pronounced.
Regarding the fact that with the exception of STC the treatment concept for implants was also used for teeth with periodontitis, it seems interesting that results at implants did not significantly differ from those at teeth. This is in contrast to previous statements in the literature proposing non-surgical therapy of periodontitis to be more efficient than that of periimplantitis. 7, 8 It can be assumed that the combination of several measures for biofilm decontamination has a higher clinical effect than single measures. 10 With the herein presented concept the authors have experienced stable results over many years. Thereby, the choice and order of the treatment steps are based on the idea that: 1) initial ultrasonic treatment leads to a biofilm reduction in the coronal part of the peri-implant pocket and the extension of the pocket orifice; 2) the subsequent STC removes granulation tissue of the pocket; 3) GPAP allows the depuration of the deep parts of the pocket; and 4) a final antiseptic treatment using povidone-iodine improves the antibacterial effect of the treatment. Whereas on teeth the removal of the inflammatory pocket epithelium in addition to subgingival scaling seems to have no additional benefit, 33 on implants STC might have an advantage since the submucosal infiltrate in peri-implantitis lesions is much more pronounced than on teeth. 21, 34 The use of subgingival air polishing for non-surgical periimplantitis therapy has already been published and recommended in the literature. 11, 12 However, the present concept has the advantage that: 1) the preceding depuration with the ultrasonic device as well as the STC extends access to the peri-implant pocket; and 2) use of a small subgingival nozzle allows improved access to deeper parts of the peri-implant pocket. The final antiseptic treatment with povidone-iodine and retreatment after 1 week has, to date, only been reported for non-surgical treatment of periodontitis with significant improvements of clinical results. 22, 24 Since clearance of the povidone-iodine leads to a > 50% reduced concentration in the pockets after 5 minutes, 23 application of povidone-iodine has been repeated to allow a higher and prolonged antibacterial effect.
In previous studies on non-surgical peri-implantitis therapy, CHX was preferentially used as an antiseptic adjuvant. 11, 12, 19, 35, 36 The choice of povidone-iodine instead of CHX in the present study is based on possible cytotoxic effects of CHX on peri-implant tissues. Although the clinical benefit of the adjuvant use of CHX differs among studies, 11, 12, 17, 19, 35, 36 in a recent in vitro study Kotsakis et al. 37 have demonstrated that CHX is able to sustainably change physicochemical properties of the titanium surface of implants and markedly inhibit the activity of osteoblasts. Considering the high substantivity of CHX on the titanium surface, 38 Kotsakis et al. 37 concluded against recommending CHX for decontamination of titanium surfaces. In contrast to CHX, exposition of osteoblast cell lines with povidoneiodine has been reported to lead to an initial decrease but long time increase of the mineralization activity. 39 Further, povidone-iodine has a wide antibacterial spectrum, including bacteria that have been associated with periodontal and peri-implant microflora. 22 Therefore, it can be supposed that application of povidone-iodine is a practice-oriented, (cost-)effective, and less cytotoxic alternative compared with use of CHX.
Another interesting aspect of the present outcomes is the observation that systemic antibiotic therapy with AM did not have a significant benefit to the changes of mean PD, CAL, and BOP values. However, in comparison with treatment without antibiotics the percentage of peri-implant pockets with treatment need (PD > 4 mm with BOP) could be significantly better reduced when AM was prescribed. This finding correlates with studies on CP in which the number of pockets with treatment need could be significantly reduced by use of the aforementioned antibiotic therapy. 40, 41 Nonetheless, the increased reduction was not significant when only deep peri-implant pockets (PD > 6 mm) or teeth were analyzed. Thus, a definitive recommendation about use of systemic antibiotics for non-surgical peri-implantitis therapy cannot be drawn, and interpretation is limited by the fact that drug adherence was not controlled and no placebos were used in the group without AM. Therefore, the decision for an adjuvant antibiotic therapy should be made individually, and the practitioner should consider severity and extent of the concomitant periodontitis as well the number of affected peri-implantitis sites with treatment need for the indication. Thereby, the potential risk of development of resistant strains 42 against amoxicillin and metronidazole must also be borne in mind and, therefore, indications carefully chosen.
CONCLUSIONS
Outcomes of this study suggest that the combination of the submucosal application of an ultrasonic device, STC, and GPAP with repeated application of 10% povidoneiodine can represent a practicable concept for non-surgical peri-implantitis therapy. However, since the study had the aim of examining the clinical effect of a completely non-surgical concept, it remains unclear to which amount the single components of the concept contributed to final outcomes. A differentiation of the effects of mechanical decontamination measures, the sole STC, and impact of the antiseptic effect of povidone-iodine should be further evaluated in future studies.
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